Literature DB >> 3024399

The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements.

R F Rando, W D Lancaster, P Han, C Lopez.   

Abstract

HPV-6vc subgenomic fragments were inserted into an enhancer-dependent expression vector for chloramphenicol acetyltransferase (CAT) and assayed for the presence of transcriptional enhancing elements. A transcriptional enhancing element was detected in the noncoding region (NCR) of the HPV-6vc viral genome when the CAT assays were performed in viral transformed human kidney cell lines (293 and 324K), in human cervical carcinoma cell lines (HeLa and Siha), and in bovine papillomavirus type 1 (BPV-1) transformed mouse cells (C127-53). The NCR region of the HPV-6b genome was only capable of enhancing transcription of the CAT gene in the HeLa cell line at a level one-third that of the HPV-6vc NCR. The HPV-6vc NCR enhancing activity in C127-53 cells was further stimulated by the addition of sodium butyrate to the growth medium. Localization of the DNA sequences in the HPV-6vc NCR responsible for enhancing transcription revealed two distinct enhancer elements. One element (HPV-6vc position 7218-7544) was active in the 293, HeLa, Siha, and C127-53 cells. The second enhancer element (HPV-6vc position 7544-7971) was only capable of stimulating transcription in HeLa, C127-53, and Siha cells. When the HPV NCR-CAT expression vectors were cotransfected with a competitor plasmid (pNCR75) into C127-53 or HeLa cells then transcriptional enhancement decreased, indicating competition of cellular factors which affect both segments of the HPV-6vc NCR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024399     DOI: 10.1016/0042-6822(86)90215-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.

Authors:  H Hirochika; T R Broker; L T Chow
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.

Authors:  J R Gage; C Meyers; F O Wettstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Alterations in the regulatory region of the human papillomavirus type 6 genome are generated during propagation in Escherichia coli.

Authors:  M S Kasher; A Roman
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6.

Authors:  T C Wu; P Mounts
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Human papillomavirus type 6 long control region and human cellular DNA contain related sequences.

Authors:  T F Hrisomalos; D L Boggs; K H Fife
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world.

Authors:  P A Heinzel; S Y Chan; L Ho; M O'Connor; P Balaram; M S Campo; K Fujinaga; N Kiviat; J Kuypers; H Pfister
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

Review 9.  Natural history of human papillomavirus infection of the anogenital tract.

Authors:  W D Lancaster; A B Jenson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

10.  Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.

Authors:  T P Cripe; T H Haugen; J P Turk; F Tabatabai; P G Schmid; M Dürst; L Gissmann; A Roman; L P Turek
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.